BySteve Forbes,
Forbes Staff.
America’s healthcare system stands at a remarkable crossroads. On one side, medical innovation is transforming lives. On the other, an underground industry is profiting from deception, endangering patients in the process.
Few developments have been as revolutionary as GLP-1 medications like Ozempic, Wegovy and Mounjaro. Once limited to diabetes care, these drugs are now helping millions combat obesity—a condition affecting roughly 40% of U.S. adults. They are reshaping medicine as profoundly as antibiotics once did.
But with every genuine breakthrough comes the counterfeiters. And this time, the stakes are life and death.
